Shares of LHC Group (NASDAQ:LHCG) have received an average recommendation of “Buy” from the ten brokerages that are covering the company, MarketBeat.com reports. Ten research analysts have rated the stock with a buy recommendation. The average 12-month target price among brokerages that have updated their coverage on the stock in the last year is $66.89.

Several analysts have weighed in on LHCG shares. Royal Bank Of Canada reaffirmed a “buy” rating and set a $69.00 target price on shares of LHC Group in a research note on Monday, May 15th. Oppenheimer Holdings, Inc. reaffirmed an “outperform” rating and set a $68.00 target price (up previously from $55.00) on shares of LHC Group in a research note on Monday, May 8th. Zacks Investment Research downgraded LHC Group from a “buy” rating to a “hold” rating in a research note on Thursday, July 6th. BidaskClub downgraded LHC Group from a “buy” rating to a “hold” rating in a research note on Tuesday, July 25th. Finally, Jefferies Group LLC boosted their price objective on LHC Group from $56.00 to $65.00 and gave the stock a “buy” rating in a research note on Monday, May 15th.

COPYRIGHT VIOLATION NOTICE: This piece was originally published by American Banking News and is the sole property of of American Banking News. If you are accessing this piece on another site, it was illegally copied and reposted in violation of U.S. & international trademark and copyright legislation. The correct version of this piece can be viewed at https://www.americanbankingnews.com/2017/08/29/lhc-group-lhcg-given-average-rating-of-buy-by-analysts.html.

In other news, COO Donald Dwayne Stelly sold 3,181 shares of the business’s stock in a transaction on Thursday, June 8th. The stock was sold at an average price of $64.97, for a total transaction of $206,669.57. Following the sale, the chief operating officer now directly owns 114,235 shares of the company’s stock, valued at $7,421,847.95. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Coliseum Capital Management, L sold 162,524 shares of the business’s stock in a transaction on Wednesday, June 7th. The stock was sold at an average price of $62.80, for a total value of $10,206,507.20. The disclosure for this sale can be found here. Insiders sold a total of 438,744 shares of company stock worth $27,298,251 in the last three months. Company insiders own 14.80% of the company’s stock.

Large investors have recently made changes to their positions in the company. Alps Advisors Inc. raised its stake in shares of LHC Group by 0.3% in the second quarter. Alps Advisors Inc. now owns 9,449 shares of the health services provider’s stock worth $641,000 after buying an additional 24 shares during the period. Eqis Capital Management Inc. raised its stake in shares of LHC Group by 0.8% in the first quarter. Eqis Capital Management Inc. now owns 6,486 shares of the health services provider’s stock worth $350,000 after buying an additional 53 shares during the period. Federated Investors Inc. PA raised its stake in shares of LHC Group by 4.2% in the second quarter. Federated Investors Inc. PA now owns 1,622 shares of the health services provider’s stock worth $110,000 after buying an additional 66 shares during the period. Louisiana State Employees Retirement System raised its stake in shares of LHC Group by 1.7% in the first quarter. Louisiana State Employees Retirement System now owns 6,100 shares of the health services provider’s stock worth $329,000 after buying an additional 100 shares during the period. Finally, Arizona State Retirement System raised its stake in shares of LHC Group by 1.3% in the second quarter. Arizona State Retirement System now owns 7,818 shares of the health services provider’s stock worth $531,000 after buying an additional 100 shares during the period. 85.88% of the stock is currently owned by institutional investors.

LHC Group (NASDAQ:LHCG) traded down 1.17% during trading on Tuesday, reaching $63.39. 70,045 shares of the company’s stock were exchanged. LHC Group has a 52 week low of $32.04 and a 52 week high of $69.35. The stock has a 50-day moving average of $62.91 and a 200-day moving average of $57.96. The stock has a market capitalization of $1.16 billion, a PE ratio of 28.05 and a beta of 0.77.

LHC Group (NASDAQ:LHCG) last announced its earnings results on Wednesday, August 2nd. The health services provider reported $0.63 earnings per share for the quarter, beating the consensus estimate of $0.54 by $0.09. The firm had revenue of $260.20 million for the quarter, compared to the consensus estimate of $254.10 million. LHC Group had a return on equity of 9.62% and a net margin of 4.13%. The firm’s revenue for the quarter was up 15.1% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.52 EPS. On average, equities research analysts anticipate that LHC Group will post $2.39 EPS for the current year.

LHC Group Company Profile

LHC Group, Inc is a holding company. The Company provides post-acute healthcare services to patients through its home nursing agencies, hospice agencies, community-based services agencies and long-term acute care hospitals (LTACHs). The Company operates through four segments: home health services, hospice services, community-based services and facility-based services.

Analyst Recommendations for LHC Group (NASDAQ:LHCG)

Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.